Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
Go back to Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy| (NASDAQ: CYCN) | Delayed: 3.79 -0.2 (5.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.99 | 52 Week High | $ | |||
| Open | $3.99 | 52 Week Low | $ | |||
| Day High | $4.27 | P/E | N/A | |||
| Day Low | $3.75 | EPS | $ | |||
| Volume | 60,012 | |||||
